Huron Acquires Frankel Group
Huron Completes Acquisition of Frankel Group

Expanding strategy, operations, analytics, and regulatory compliance offerings to life sciences companies » MORE

CRM Briefing
Clinical Research Management Briefing

Sign up to receive our Clinical Research Management Briefing, a weekly roundup of top stories. »Subscribe | »Current Issue

International Medical Device Compliance Code Compendium
The International Medical Device Compliance Code Compendium

We invite you to register for this complimentary online resource. » More

Huron Life Sciences

Huron Life Sciences assists the continuum of life sciences organizations, from biopharmaceutical  and generic companies, device and diagnostic manufacturers, to law and investment firms, and other organizations that support the life sciences industry, translate the driver of our industry’s value, the science of medicine, into strategies that resonate both clinically and commercially, and are able to be executed through the regulatory and governmental hurdles that ultimately ensure patient safety. 

 

Huron Life Sciences Insights

Resource: Clinical Research Management Briefing February 15, 2016
The Clinical Research Management Briefing (CRMB) is a weekly newsletter that Huron Consulting Group sends out to clients and interested parties.» MORE...

Resource: Clinical Research Management Briefing February 8, 2016
The Clinical Research Management Briefing (CRMB) is a weekly newsletter that Huron Consulting Group sends out to clients and interested parties. » MORE...

Webinar: Covered Outpatient Drugs Final Rule Series Part 1 - Implications for GP Professionals
The Huron team presented it's in-depth review of the CMS Covered Outpatient Drugs Final Rule and the ramifications for manufacturers, along with guest speaker Joe Metro from Reed Smith. » MORE...

Expertise

PROFESSIONALS
Alt text

David Gilman

Managing Director

Lester Cheng

Lester Cheng

Managing Director

Alt text

Marc Tomassi

Managing Director

Mark Linver

Mark Linver

Managing Director

alt text

Nathan Dowden

Managing Director

Paul J. Silver

Paul J. Silver

Managing Director and Practice Leader

Subscribe to Huron Insights

Stay current with the trends, developments and ideas that impact you. » MORE

Highlights

The Proposed Guidance covers many areas of the 340B Program and Huron believes that HRSA has been focused on the critical components of program integrity as well as guidance and clarification across several key areas.

 » MORE

With more than a full year of transaction level spend data publicly available, an opportunity exists for Life Sciences companies to utilize the Open Payments data in order to identify potential compliance risks, as well as potentially gain insights into commercial business functions.

 » MORE